MedTrace Logo

Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder

NCT00688142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2010-03-31

No results posted yet for this study

Summary

The investigators hypothesize that in patients with shift work sleep disorder, armodafinil will specifically increase brain activity in the frontal cortex parallel with improvements in deficits of fundamental mechanisms of attention.

Conditions

  • Shift Work Sleep Disorder

Sponsors & Collaborators

  • Cephalon

    collaborator INDUSTRY

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Christopher Drake, Ph.D. · Henry Ford Hospital Sleep Disorders & Research Center

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00688142 on ClinicalTrials.gov